John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$976M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$219M |
| 3 |
Humana
HUM
|
+$215M |
| 4 |
Pinterest
PINS
|
+$214M |
| 5 |
Snowflake
SNOW
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$301M |
| 2 |
Tesla
TSLA
|
+$254M |
| 3 |
Nike
NKE
|
+$248M |
| 4 |
Procter & Gamble
PG
|
+$233M |
| 5 |
Pfizer
PFE
|
+$232M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.09% |
| 2 | Financials | 10.23% |
| 3 | Consumer Discretionary | 10.17% |
| 4 | Healthcare | 10.17% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
NextDecade
NEXT
$1.99B
| $510K | ﹤0.01% |
106,978
+25,600
| +31% | +$119K |
|
2402
Brink's
BCO
$4.57B
| $510K | ﹤0.01% |
5,800
+2,400
| +71% | +$184K |
|
2403
Arbutus Biopharma
ABUS
$1.03B
| $510K | ﹤0.01% |
203,835
+178,523
| +705% | +$350K |
|
|
DFTX
2404
Definium Therapeutics
DFTX
$6.02B
| $509K | ﹤0.01% |
139,096
-18,343
| -12% | -$55.2K |
|
2405
PUT
DexCom
DXCM
$33.6B
| $509K | ﹤0.01% |
4,100
-20,100
| -83% | -$2.05M |
|
2406
iShares ESG MSCI USA Leaders ETF
SUSL
$1.23B
| $506K | ﹤0.01% |
6,000
-1,700
| -22% | -$134K |
|
|
KC
2407
Kingsoft Cloud Holdings
KC
$3.15B
| $505K | ﹤0.01% |
133,600
-38,600
| -22% | -$176K |
|
2408
Upbound Group
UPBD
$1.13B
| $504K | ﹤0.01% |
14,831
+6,700
| +82% | +$200K |
|
2409
Argan
AGX
$6.32B
| $503K | ﹤0.01% |
10,760
-3,537
| -25% | -$161K |
|
|
DFSU
2410
Dimensional US Sustainability Core 1 ETF
DFSU
$2.35B
| $501K | ﹤0.01% |
+16,100
| New | +$464K |
|
2411
Alerus Financial
ALRS
$824M
| $501K | ﹤0.01% |
22,371
-2,462
| -10% | -$46.5K |
|
2412
SEACOR Marine Holdings
SMHI
$263M
| $501K | ﹤0.01% |
39,771
+25,904
| +187% | +$332K |
|
2413
Vital Farms
VITL
$477M
| $498K | ﹤0.01% |
+31,749
| New | +$402K |
|
2414
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$6.88B
| $497K | ﹤0.01% |
+4,780
| New | +$416K |
|
|
YALA
2415
Yalla Group
YALA
$853M
| $497K | ﹤0.01% |
81,020
+27,787
| +52% | +$158K |
|
2416
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
$291M
| $496K | ﹤0.01% |
13,900
+200
| +1% | +$6.77K |
|
2417
Euroseas
ESEA
$543M
| $496K | ﹤0.01% |
+19,569
| New | +$442K |
|
2418
Cushman & Wakefield Ltd
CWK
$3.49B
| $496K | ﹤0.01% |
45,914
+22,323
| +95% | +$186K |
|
2419
Ocular Therapeutix
OCUL
$2.39B
| $495K | ﹤0.01% |
111,000
-5,100
| -4% | -$15.1K |
|
|
GTHX
2420
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $494K | ﹤0.01% |
162,063
+71,663
| +79% | +$135K |
|
2421
Atea Pharmaceuticals
AVIR
$436M
| $494K | ﹤0.01% |
161,909
+107,813
| +199% | +$327K |
|
2422
Duluth Holdings
DLTH
$144M
| $493K | ﹤0.01% |
+91,697
| New | +$480K |
|
2423
Cardlytics
CDLX
$25.2M
| $493K | ﹤0.01% |
5,350
+270
| +5% | +$27.4K |
|
2424
Oil-Dri
ODC
$1.33B
| $492K | ﹤0.01% |
14,670
+1,798
| +14% | +$54.6K |
|
2425
Alcon
ALC
$35.5B
| $491K | ﹤0.01% |
6,290
-2,727
| -30% | -$201K |
|
Similar funds
John Overdeck's Q4 2023 Portfolio in Review
As of Q4 2023, John Overdeck held 3,484 positions worth $43.5B, up 17% from $37.2B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
John Overdeck's Q4 2023 filing shows 550 new, 1,237 increased, 1,116 reduced and 366 closed positions. Its largest new stake was Becton Dickinson: 732,254 shares worth $179M. The largest sale was Palantir, an estimated $301M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
- John Overdeck's largest Q4 2023 buy was Becton Dickinson: 732,254 shares worth $179M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $976M increase.
- John Overdeck's biggest Q4 2023 reduction was Palantir, cutting an estimated $301M.
- John Overdeck fully exited Tesla in Q4 2023, selling an estimated $254M.
- John Overdeck's ten largest holdings make up 9.3% of its $43.5B portfolio in Q4 2023.
- John Overdeck opened 550 new positions and closed 366 in Q4 2023.
- John Overdeck's portfolio value rose 17% quarter-over-quarter to $43.5B.
Based on Two Sigma Investments's 13F filing for Q4 2023, filed 14 Feb 2024.